Skip to main content
. 2011 Jan 20;2010:365318. doi: 10.1155/2010/365318

Table 5.

Median survival and disease progression in patients with isolated trisomy 14.

Features MDS (n = 7) MDS/MPN (n = 5) AML (n = 4)
Median survival (range) (month) 28 (10.5–75) 31.5 (31–32) 9 (2–12)
Leukemic transformation 43% 20% N/A
Median interval of disease progression (month) 7.75 29 N/A

MDS: myelodysplastic syndrome; MDS/MPN: myelodysplastic/myeloproliferative neoplasms; AML: acute myeloid leukemia; N/A: not applicable.